skincare |skincare secret tips|young looking skin
Posts tagged News
News of treatment for psoriasis
Jul 19th
PhotoMedex of “win-win” contest offers free treatments XTRAC laser phototherapy of psoriasis deserves the …
In honor of National Awareness Month psoriasis in August, PhotoMedex, Inc. NASDAQ: GAD, an innovator of medical devices, has today launched the “wanting to win” contest, an opportunity for six patients with psoriasis deserves to win a series of treatments with the excimer laser XTRAC laser.The XTRAC is the only clinically proven, FDA approved excimer laser dermatology independent security …
Read more at href=”http://pitch.pe/160357″> rel=”nofollow” PitchEngine
J & J profit 2Q falls 20 percent, still beats view
Healthcare giant Johnson & Johnson said Tuesday its second-quarter earnings fell nearly 20 percent due to restructuring costs, litigation and recovery and increased spending on launching products, manufacturing and research.
Read more at href=”http://news.yahoo.com/j-j-2q-profit-drops-20-percent-still-120613966.html”> rel=”nofollow” AP via Herald Tribune
J & J profit Analyst Estimates shock pulse of new drugs
Johnson & Johnson, the second largest manufacturer of products for healthcare, said the earnings beat analysts ‘estimates’, driven by the weak dollar and new drugs for prostate cancer and psoriasis.
Read more about
Latest News Scalp Psoriasis
Jul 18th
PhotoMedex of “win-win” contest offers free treatments XTRAC laser phototherapy of psoriasis deserves the …
In honor of National Awareness Month psoriasis in August, PhotoMedex, Inc., an innovator of medical devices, has today launched the “wanting to win” contest, an opportunity for six patients with psoriasis deserves to win a series of treatments with the excimer laser XTRAC.
Read more at href=”http://biz.yahoo.com/prnews/110718/de36290.html?.v=1″> rel=”nofollow” PR Newswire via Yahoo!
press release
LEO Pharma Inc. Posted on: July 16, 11 LEO Pharma Inc., a U.S. subsidiary wholly owned by LEO Pharma A / S, responsible for Taclonex ® brand products, announced today that LEO Pharma A / S and the top Biomedical Research Institute, Scripps Research Institute have entered into a research collaboration .
Read more at rel=”nofollow” href=”http://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=44214″> Monster
LEO Pharma A / S and the Scripps Research Institute Enter Collaboration
PARSIPPANY, NJ – (BUSINESS WIRE) – LEO Pharma Inc., a U.S. subsidiary wholly owned by LEO Pharma A / S, responsible for Taclonex ® brand products, announced today that LEO Pharma A / S and the top Biomedical Research Institute, The Scripps Research Institute have entered into a research collaboration. The collaboration between LEO Pharma and the Scripps Research Institute has established the link …
Read more about
dermatological : World Market 2011-2026
Reportlinker.com announces that a market research report is available in its new catalog:
Read more at href=”http://www.businesswire.com/news/home/20110715005853/en/LEO-Pharma-Scripps-Research-Institute-Enter-Collaboration”> rel=”nofollow” PR Newswire via Yahoo!
Related Blogs
Psoriasis Ointment News
Jul 16th
press release
LEO Pharma Inc. Posted on: July 16, 11 LEO Pharma Inc., a U.S. subsidiary wholly owned by LEO Pharma A / S, responsible for Taclonex ® brand products, announced today that LEO Pharma A / S and the top Biomedical Research Institute, Scripps Research Institute have entered into a research collaboration .
Read more at rel=”nofollow” href=”http://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=44214″> Monster
LEO Pharma A / S and the Scripps Research Institute Enter Collaboration
PARSIPPANY, NJ – (BUSINESS WIRE) – LEO Pharma Inc., a U.S. subsidiary wholly owned by LEO Pharma A / S, responsible for Taclonex ® brand products, announced today that LEO Pharma A / S and the top Biomedical Research Institute, The Scripps Research Institute have entered into a research collaboration. The collaboration between LEO Pharma and the Scripps Research Institute has established the link …
Read more about
Upsher-Smith launches Trianex (TM) 0.05% (triamcinolone acetonide cream): a corticosteroid with a strong …
Maple Grove, Minnesota, July 11, 2011 / PRNewswire / – Today Upsher-Smith Laboratories, Inc. has announced the launch of Trianex (TM) 0.05% (triamcinolone acetonide ointment), a recipe that gives the feeling of topical corticosteroid of a cream with the strength of a perfume. Trianex (TM) combines triamcinolone, the No. 1 prescribed rate of topical corticosteroids (1), with a nice cream as a base for …
Read more about
